Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in vascular tissue engineering.

Anita C Thomas1, Gordon R Campbell, Julie H Campbell

  • 1Centre for Research in Vascular Biology, University of Queensland, Brisbane, QLD 4072, Australia.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial Infarction.

JACC. Basic to translational science·2025
Same author

CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion.

Cardiovascular research·2025
Same author

Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression.

Molecular therapy. Nucleic acids·2024
Same author

The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.

Cardiovascular diabetology·2023
Same author

Murine studies and expressional analyses of human cardiac pericytes reveal novel trajectories of SARS-CoV-2 Spike protein-induced microvascular damage.

Signal transduction and targeted therapy·2023
Same author

The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy.

Cardiovascular research·2023
Same journal

Adventitial Melanocytosis ("Blue nevus") of the Aorta.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Lipomatous Hamartoma of the Semilunar Valve Exhibits Molecular Genetic Characteristics of Lipoma.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodeling.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Burden of cardiovascular disease in victims of fatal intoxication: An autopsy study.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Immune cells in cardiac homeostasis and disease.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
See all related articles

Developing artificial arteries addresses limitations in traditional bypass grafting materials. Tissue-engineered and bioreactor-derived vascular grafts offer promising alternatives for vascular reconstruction.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Vascular Surgery

Background:

  • Autologous tissues for bypass grafting are limited in supply and suitability for repeat procedures.
  • Synthetic grafts face challenges, especially thrombosis in small-diameter arteries.
  • Graft requirements include biocompatibility, thromboresistance, mechanical integrity, and cost-effective production.

Purpose of the Study:

  • To explore alternative materials for vascular grafting beyond autologous tissues and conventional synthetics.
  • To review current advancements in tissue-engineered and artificial artery development.
  • To identify key characteristics for successful vascular graft replacements.

Main Methods:

  • Coating synthetic grafts with biological agents or cells to improve anticoagulatory properties.

Related Experiment Videos

  • Utilizing matrix templates or acellular extracellular matrix tubes infiltrated with cultured cells.
  • Developing tissue-engineered blood vessels from cultured human vascular cells.
  • Creating artificial arteries from peritoneal granulation tissue in bioreactors.

    • Main Results:

    • Engineered vessels mimic native artery characteristics.
    • Bioreactor-derived artificial arteries leverage the body's healing response.
    • Cell-infiltrated grafts show potential for host cell colonization and functional integration.
    • Ongoing research focuses on optimizing graft biocompatibility and thromboresistance.

    Conclusions:

    • Tissue-engineered and bioreactor-derived vascular grafts represent promising alternatives to current bypass grafting materials.
    • These advanced graft technologies aim to overcome limitations of autologous tissues and synthetic implants.
    • Further development is crucial to meet the complex demands of vascular reconstruction.